IRIS
SCUTERI, DAMIANA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.864
AS - Asia 1.238
EU - Europa 515
SA - Sud America 249
Continente sconosciuto - Info sul continente non disponibili 144
AF - Africa 20
OC - Oceania 12
Totale 4.042
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.806
SG - Singapore 568
CN - Cina 297
IT - Italia 272
BR - Brasile 200
IN - India 110
VN - Vietnam 96
BD - Bangladesh 69
GB - Regno Unito 59
DE - Germania 42
HK - Hong Kong 36
CA - Canada 34
FI - Finlandia 23
SE - Svezia 21
MX - Messico 16
EC - Ecuador 15
NL - Olanda 14
AR - Argentina 13
IQ - Iraq 12
RU - Federazione Russa 12
FR - Francia 10
EE - Estonia 9
PL - Polonia 9
UA - Ucraina 9
ZA - Sudafrica 9
TR - Turchia 8
AT - Austria 7
IE - Irlanda 7
JP - Giappone 7
PE - Perù 7
AU - Australia 6
ES - Italia 6
ID - Indonesia 6
NZ - Nuova Zelanda 6
CO - Colombia 5
RO - Romania 5
TW - Taiwan 5
CL - Cile 4
EU - Europa 4
HN - Honduras 3
MA - Marocco 3
NP - Nepal 3
PK - Pakistan 3
TH - Thailandia 3
XK - ???statistics.table.value.countryCode.XK??? 3
HR - Croazia 2
IR - Iran 2
JO - Giordania 2
PS - Palestinian Territory 2
PY - Paraguay 2
TN - Tunisia 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
AO - Angola 1
AZ - Azerbaigian 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BS - Bahamas 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EG - Egitto 1
ET - Etiopia 1
GE - Georgia 1
GT - Guatemala 1
IL - Israele 1
LT - Lituania 1
LV - Lettonia 1
MD - Moldavia 1
MK - Macedonia 1
MU - Mauritius 1
OM - Oman 1
PH - Filippine 1
PT - Portogallo 1
SA - Arabia Saudita 1
SV - El Salvador 1
TG - Togo 1
Totale 3.905
Salva come PNG Salva come JPEG
Città #
San Jose 447
Ashburn 193
Dallas 174
Singapore 174
Santa Clara 113
Bengaluru 89
Hefei 88
Council Bluffs 87
Beijing 60
Phoenix 50
Chandler 48
Ho Chi Minh City 44
Milan 44
Princeton 39
Lawrence 38
Chicago 36
London 36
Hong Kong 34
Los Angeles 25
New York 23
Hanoi 22
Wilmington 22
São Paulo 21
Catanzaro 20
Munich 18
Helsinki 16
Rome 16
Redwood City 12
Des Moines 11
Naples 10
Palermo 9
Warsaw 9
Ann Arbor 8
Birmingham 8
Boston 8
Brooklyn 8
Atlanta 7
Chennai 7
Lima 7
Montreal 7
Ottawa 7
Toronto 7
Turku 7
Vallefiorita 7
Washington 7
Florence 6
Mexico City 6
San Francisco 6
Shenzhen 6
Tokyo 6
Amsterdam 5
Boardman 5
Dublin 5
Guangzhou 5
Johannesburg 5
Manchester 5
Quito 5
Rio de Janeiro 5
St Petersburg 5
The Dalles 5
Assago 4
Auckland 4
Buffalo 4
Catania 4
Charlotte 4
Mumbai 4
Orem 4
Palizzi Marina 4
San Ferdinando 4
Shanghai 4
Springfield 4
Stockholm 4
Taipei 4
Ankara 3
Aversa 3
Baghdad 3
Bogotá 3
Bologna 3
Brasília 3
Columbus 3
Curitiba 3
Erbil 3
García 3
Hackney 3
Haiphong 3
Horia 3
Itaquaquecetuba 3
Louisville 3
Philadelphia 3
Reggio Calabria 3
Rende 3
Riobamba 3
Rizziconi 3
Salvador 3
San Nicola Manfredi 3
San Pedro Sula 3
Seattle 3
Thái Nguyên 3
Viamão 3
Wuhan 3
Totale 2.336
Salva come PNG Salva come JPEG
Nome #
Effects of Palmitoylethanolamide (PEA) on Nociceptive, Musculoskeletal and Neuropathic Pain: Systematic Review and Meta-Analysis of Clinical Evidence 183
Translational Impact of Genetics and Epigenetics of CGRP System on Chronic Migraine Treatment with Onabotulinumtoxin A and Other Biotech Drugs 94
Benefits and risks associated with cannabis and cannabis derivatives use 83
Anxiolytic-Like Effects of Bergamot Essential Oil Are Insensitive to Flumazenil in Rats. 74
Pharmacoutilization data-driven artificial intelligence–assisted diagnosis algorithm to improve the pharmacological treatment of pain and agitation in patients suffering from severe dementia 71
Efficacy of therapeutic intervention with NanoBEO to manage agitation and pain in patients suffering from severe dementia: a pilot clinical trial 70
Neuropharmacological Properties of the Essential Oil of Bergamot for the Clinical Management of Pain-Related BPSDs. 65
Pain assessment and treatment in dementia at the time of coronavirus disease covid-19 64
Clinical and Market Analysis of NanoBEO: A Public-Worth, Innovative Therapy for Behavioral and Psychological Symptoms of Dementia (BPSD)—Emerging Evidence and Its Implications for a Health Technology Assessment (HTA) and Decision-Making in National Health Systems 62
Neuropharmacology of the Neuropsychiatric Symptoms of Dementia and Role of Pain: Essential Oil of Bergamot as a Novel Therapeutic Approach. 59
2-pentadecyl-2-oxazoline prevents cognitive and social behaviour impairments in the Amyloid β-induced Alzheimer-like mice model: Bring the α2 adrenergic receptor back into play 58
Focus on zavegepant: the first intranasal third-generation gepant 58
New Trends in Migraine Pharmacology: Targeting Calcitonin Gene-Related Peptide (CGRP) With Monoclonal Antibodies. 58
Antinociceptive effect of inhalation of the essential oil of bergamot in mice 58
Opioids in Post-stroke Pain: A Systematic Review and Meta-Analysis 57
Impact of nutraceuticals on glaucoma: A systematic review 56
Benefits and risks associated with cannabis and cannabis derivatives use 56
Antispasmodic Effect of Bergamot Essential Oil on Rat Isolated Gut Tissues 55
Aging brain: In search for better neurotherapeutics 55
Efficacy and safety of mAbs anti-CGRP/CGRP R (eptinezumab and erenumab) or atogepant in combination with onabotulinumtoxinA in refractory chronic migraine: a clinical trial protocol 53
Genetic variants of CGRP signaling pathway in migraine: impact on novel therapeutics 52
Biphasic Hormetic-like Effect of Lebecetin, a C-type Lectin of Snake Venom, on Formalin-induced Inflammation in Mice 51
Aromatherapy and Aromatic Plants for the Treatment of Behavioural and Psychological Symptoms of Dementia in Patients with Alzheimer's Disease: Clinical Evidence and Possible Mechanisms 51
Role of 5-HT1A receptor in the anxiolytic-relaxant effects of bergamot essential oil in rodent 51
New trends in pain research: from basic research to clinical translation 50
Evidence on the neuroprotective properties of brimonidine in glaucoma 50
Comparing eptinezumab with onabotulinumtoxinA in the treatment of chronic migraine: a real-world evidence study 50
Analgesic Characteristics of NanoBEO Released by an Airless Dispenser for the Control of Agitation in Severe Dementia 48
Pattern of treatment of behavioural and psychological symptoms of dementia and pain: evidence on pharmacoutilization from a large real-world sample and from a centre for cognitive disturbances and dementia 47
Effects of Aging on Formalin-Induced Pain Behavior and Analgesic Activity of Gabapentin in C57BL/6 Mice 47
Pattern of triptans use: A retrospective prescription study in Calabria, Italy 47
Contribution of Histamine to Nociceptive Behaviors Induced by Intrathecally Administered Cholecystokinin-8 45
Proposal of combination therapies to treat refractory chronic migraine 45
Basic, Translational, and Clinical Research on Dementia 44
Efficacy of Essential Oils in Relieving Cancer Pain: A Systematic Review and Meta-Analysis 44
Bergamot Essential Oil Attenuates Anxiety-Like Behaviour in Rats 44
Combination of anti-CGRP/CGRP-R mAbs with onabotulinumtoxin A as a novel therapeutic approach for refractory chronic migraine: a retrospective study of real-world clinical evidence and a protocol for a double-blind, randomized clinical trial to establish the efficacy and safety 44
Is there a rational basis for cannabinoids research and development in ocular pain therapy? A systematic review of preclinical evidence 43
Behavioral Effects of Continuously Administered Bergamot Essential Oil on Mice With Partial Sciatic Nerve Ligation 43
Bergamot rehabilitation AgaINst agitation in dementia (BRAINAID): Study protocol for a randomized, double-blind, placebo-controlled trial to assess the efficacy of furocoumarin-free bergamot loaded in a nanotechnology-based delivery system of the essential oil in the treatment of agitation in elderly affected by severe dementia 43
The need for better access to pain treatment: learning from drug consumption trends in the USA. 42
Development and translation of nanobeo, a nanotechnology-based delivery system of bergamot essential oil deprived of furocumarins, in the control of agitation in severe dementia 41
CB1R, CB2R and TRPV1 expression and modulation in in vivo, animal glaucoma models: A systematic review 41
Pooled Analysis of Real-World Evidence Supports Anti-CGRP mAbs and OnabotulinumtoxinA Combined Trial in Chronic Migraine 40
Pain and agitation treatment in severe dementia patients: The need for Italian Mobilization–Observation–Behavior–Intensity–Dementia (I-MOBID2) pain scale translation, adaptation and validation with psychometric testing 40
Aromatherapy in Stroke Patients: Is it Time to Begin? 39
Essential oils for the control of the neuropsychiatric symptoms of dementia. A pharmacotechnological appraisal 39
Dementia and COVID-19: A Case Report and Literature Review on Pain Management 39
Eptinezumab for the treatment of migraine 39
New trends in pharmacological control of neuropsychiatric symptoms of dementia 39
Aging Brain: In Search of Better Neurotherapeutics 38
Editorial: “Novel Pain Therapeutics: From Basic Research to Clinical Translation and Rehabilitation” 38
Role of CGRP pathway polymorphisms in migraine: a systematic review and impact on CGRP mAbs migraine therapy 37
Scopolamine-Induced Memory Impairment in Mice: Effects of PEA-OXA on Memory Retrieval and Hippocampal LTP 36
Safety of Onabotulinumtoxin A in Chronic Migraine: A Systematic Review and Meta-Analysis of Randomized Clinical Trials 36
Translational Value of the Transdermal Administration of Bergamot Essential Oil and of Its Fractions 36
Preclinical Characterization of Antinociceptive Effect of Bergamot Essential Oil and of Its Fractions for Rational Translation in Complementary Therapy 36
Evidence for accuracy of pain assessment and painkillers utilization in neuropsychiatric symptoms of dementia in Calabria region, Italy 36
Pharmacokinetic interactions between herbal medicines and drugs: Their mechanisms and clinical relevance 36
Exploitation of thermal sensitivity and hyperalgesia in a mouse model of dystonia 36
Homo-AMPA in the periaqueductal grey modulates pain and rostral ventromedial medulla activity in diabetic neuropathic mice 36
Essential oils-induced analgesia and related translation for the management of agitation in dementia 35
Efficacy of essential oils in pain: A systematic review and meta-analysis of preclinical evidence 35
Pharmacotechnological Advances for Clinical Translation of Essential Oils for the Treatment of Pain and Agitation in Severe Dementia 34
Evaluation of putative differences in vessel density and flow area in normal tension and high-pressure glaucoma using OCT-angiography 34
Effect of genotype on individual response to the pharmacological treatment of glaucoma: a systematic review and meta-analysis 34
TRANSLATION OF BERGAMOT ESSENTIAL OIL IN CLINICAL TRIAL FOR CONTROL OF BEHAVIOURAL AND PSYCHOLOGICAL SYMPTOMS OF DEMENTIA 34
GABAA/Benzodiazepine Receptor Complex in the Dorsal Hippocampus Mediates the Effects of Chrysin on Anxiety-Like Behaviour in Female Rats 34
Hericenone C attenuates the second phase of formalin-induced nociceptive behavior by suppressing the accumulation of CD11c-positive cells in the paw epidermis via phosphorylated P65 33
Requirements for Translation in Clinical Trials of Aromatherapy: The Case of the Essential Oil of Bergamot (BEO) for Management of Agitation in Severe Dementia 33
ROBOCOP (ROBOtic Care of Poststroke Pain): Study Protocol for a Randomized Trial to Assess Robot-Assisted Functional and Motor Recovery and Impact on Poststroke Pain Development 32
PEA-OXA ameliorates allodynia, neuropsychiatric and adipose tissue remodeling induced by social isolation 32
Opioids Resistance in Chronic Pain Management 32
Targeting Neuroplasticity for the Management of Pain and Agitation in Alzheimer’s Disease via Bergamot Nanotherapy 32
Dementia therapeutics and cognitive rehabilitation 31
Progress in the Treatment of Migraine Attacks: From Traditional Approaches to Eptinezumab 31
Effect of gabapentin in a neuropathic pain model in mice overexpressing human wild-type or human mutated torsin a 31
Real world considerations for newly approved CGRP receptor antagonists in migraine care 30
NAbiximols Clinical Translation To the treatment of Pain and Agitation In Severe Dementia (NACTOPAISD): Clinical trial protocol 30
Role of Spinal Cholecystokinin Octapeptide, Nociceptin/Orphanin FQ, and Hemokinin-1 in Diabetic Allodynia 30
Pharmacological Treatment of Pain and Agitation in Severe Dementia and Responsiveness to Change of the Italian Mobilization-Observation-Behavior-Intensity-Dementia (I-MOBID2) Pain Scale: Study Protocol 30
Motor behavior induced by bergamot essential oil in experimental tasks is differentially modulated by pretreatment with metabotropic glutamate receptor 2/3 or 5 antagonists 30
Unbiased research is needed for rational translation of essential oils in clinic 29
Diabetic retinopathy and age-related macular degeneration: a survey of pharmacoutilization and cost in Calabria, Italy. 26
Exploitation of Autophagy Inducers in the Management of Dementia: A Systematic Review 24
Transgenic Mice for the Translational Study of Neuropathic Pain and Dystonia 24
Editorial: Plant secondary metabolites: Potential therapeutic implications in neuropsychiatric disorders 23
Epigenetic and nanotechnology alliance to fight stroke-induced brain damage 20
Gas Chromatography–Mass Spectroscopy (GC-MS) Simultaneous Determination of Limonene, Linalool, and Linalyl Acetate in Rat Plasma Following Transdermal Administration of the Essential Oil of Bergamot Loaded Onto Solid Lipid Nanoparticles (NanoBEO) 15
Risk factors associated to disability in primary headaches: a systematic review to inform future iterations of the Global Burden of Disease Study 12
Epigenetics in migraine: the Junior Editorial Board Members’ vision 11
Awareness, attitudes, and clinical practices related to medication-overuse headache among Italian pharmacists: results from a cross-sectional survey 9
Pharmacological mechanisms underlying neurovascular alterations related to resistant and refractory migraine: CGRP pathways and beyond 9
Real-World Evolution of Prescribing Patterns and Safety Profiles of Biologic and Targeted Synthetic Therapies in Inflammatory Rheumatic Diseases: A Comparative Study Between 2018–2019 and 2023–2024 9
Chronic migraine management with onabotulinumtoxinA and anti-CGRP/R monoclonal antibodies in an Italian real-world setting: update on therapeutic appropriateness and an emerging role of pharmacy 8
Hericenone C exhibits anti-nociceptive effects through RORα-mediated suppression of TLR4 transcription 8
Positioning rimegepant in migraine prophylaxis: updated evidence and emerging perspectives 7
Beyond triptans in menstrual migraine: the emerging role of CGRP-targeted therapies 3
Totale 4.042
Salva come PNG Salva come JPEG
Categoria #
all - tutte 35.525
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.525
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022115 0 0 0 13 5 22 9 21 6 15 23 1
2022/2023229 78 9 7 9 17 30 6 21 23 8 17 4
2023/2024194 44 18 14 10 14 45 7 6 4 5 24 3
2024/2025908 125 58 35 21 87 104 20 18 157 44 82 157
2025/20262.014 86 314 198 280 190 77 261 131 205 108 53 111
2026/2027450 28 112 272 38 0 0 0 0 0 0 0 0
Totale 4.042